KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Total Current Liabilities: 2014-2024

Historic Total Current Liabilities for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Dec 2024 value amounting to $97.8 million.

  • Aurinia Pharmaceuticals' Total Current Liabilities fell 3.04% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year decrease of 3.04%. This contributed to the annual value of $97.8 million for FY2024, which is 26.66% up from last year.
  • According to the latest figures from FY2024, Aurinia Pharmaceuticals' Total Current Liabilities is $97.8 million, which was up 26.66% from $77.2 million recorded in FY2023.
  • Aurinia Pharmaceuticals' Total Current Liabilities' 5-year high stood at $97.8 million during FY2024, with a 5-year trough of $32.0 million in FY2020.
  • In the last 3 years, Aurinia Pharmaceuticals' Total Current Liabilities had a median value of $77.2 million in 2023 and averaged $73.7 million.
  • Data for Aurinia Pharmaceuticals' Total Current Liabilities shows a peak YoY surged of 183.28% (in 2020) over the last 5 years.
  • Aurinia Pharmaceuticals' Total Current Liabilities (Yearly) stood at $32.0 million in 2020, then increased by 27.03% to $40.6 million in 2021, then grew by 13.44% to $46.1 million in 2022, then soared by 67.41% to $77.2 million in 2023, then increased by 26.66% to $97.8 million in 2024.